The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

September 30, 2015

Conditions
Primary IgA Nephropathy
Interventions
DRUG

NEFECON

All patients will receive a maximum recommended daily dose of an ACEI and/or ARB (or maximum tolerated dose not exceeding the maximum recommended daily dose) for the duration of the treatment and follow-up phases.

OTHER

Placebo

All patients will receive a maximum recommended daily dose of an ACEI and/or ARB (or maximum tolerated dose not exceeding the maximum recommended daily dose) for the duration of the treatment and follow-up phases.

Trial Locations (58)

Unknown

University Hospital of Antwerp, Antwerp

Imelda Hospital, Bonheiden

Ghent University Hospital, Ghent

University Hospitals Leuven, Leuven

Heilig Hartziekenhuis Roeselare-Menen, Roeselare

University Hospital, Olomouc

Charles University & General University Hospital, Prague

Institut klinické a experimentální medicíny, Prague

Rigshospitalet, Copenhagen

Herlev Hospital, Herlev

Odense University Hospital, Odense

Helsinki University Central Hospital, Helsinki

Tampere University Hospital, Tampere

Turku University Central Hospital, Turku

RWTH Aachen, Aachen

Klinikum Augsburg, Augsburg

Charité Hospital, Berlin

Charité-Virchow Clinic, Berlin

Vivantes Klinikum im Friedrichshain, Berlin

Klinikum-Bremen-Mitte, Bremen

University Hospital Carl Gustav Carus, Dresden

Studienzentrum Karlstrasse, Düsseldorf

Universitätsklinikum Erlangen, Erlangen

Universitätsmedizin Göttingen, Göttingen

University Hospital, Heidelberg

University of Jena, Jena

Universitätsklinikum Magdeburg, Magdeburg

Universität München, Munich

Universitätsklinikum Münster, Münster

Universitätsklinikum Regensburg, Regensburg

Deutsche Klinik für Diagnostik, Wiesbaden

Würzburg University Hospital, Würzburg

Policlinico di Bari, Bari

Azienda Ospedaliera G. Brotzu, Cagliari

Ospedale A Manzoni, Lecco

Bassini Hospital, Milan

Ospedale S. G. Bosco, Torino

Belcolle Hospital, Viterbo

University Medical Center, Leiden

Fundación Puigver, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

12 de Octubre Hospital, Madrid

Fundación Jimenez Diaz Hospital, Madrid

Hospital Universitario Gregorio Marañon, Madrid

Central sjukhuset, Karlstad

Karlstad Central Hospital, Karlstad

University Hospital, Linköping

Danderyds Hospital, Stockholm

Karolinska University Hospital, Stockholm

Uppsala University Hospital, Uppsala

Belfast City Hospital, Belfast

Ulster Hospital, Belfast

Royal Derby Hospital, Derby

Edinburgh Royal Infirmary, Edinburgh

Western Infirmary, Glasgow

The Leeds Teaching Hospitals NHS Trust, Leeds

Leicester General Hospital, Leicester

James Cook University Hospital, Middlesbrough

Sponsors
All Listed Sponsors
lead

Calliditas Therapeutics AB

INDUSTRY